warnings
WARNINGS: Stop use and ask a physician if symptoms persist for more than 3 days or worsen.
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
| Harmonized routes |
|---|
| SUBLINGUAL |
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Belladonna 200ck | openfda.brand_name | |
| generic name | ATROPA BELLADONNA | openfda.generic_name | |
| manufacturer name | SEVENE USA | openfda.manufacturer_name | |
| ndc | package | 76472-3005-1 | openfda.package_ndc |
| ndc | product | 76472-3005 | openfda.product_ndc |
| ndc11 | package | 76472300501 | derived:openfda.package_ndc |
| spl id | 2ddc212b-814d-d790-e063-6394a90aa58e | id | |
| spl set id | c8d30961-fc0d-c8f1-e053-2995a90a2a8f | set_id | |
| unii | WQZ3G9PF0H | openfda.unii |
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse event summaries are temporarily unavailable. Other product information remains available.